NCT06858982

Brief Summary

The PMMHRI-Pitavastatin Registry is a non-interventional, single-center registry conducted at the Polish Mother's Memorial Hospital Research Institute (PMMHRI). Established in January 2024, the registry enrolls all patients from the Department of Cardiology and Adult Congenital Heart Diseases, the Department of Endocrinology, as well as outpatient cardiology and endocrinology clinics who are prescribed pitavastatin.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
31mo left

Started Jun 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Jun 2024Dec 2028

Study Start

First participant enrolled

June 1, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 27, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 5, 2025

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2028

Expected
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

March 5, 2025

Status Verified

February 1, 2025

Enrollment Period

3.7 years

First QC Date

February 27, 2025

Last Update Submit

February 27, 2025

Conditions

Hypercholesterolemia

Keywords

hypercholesterolemiapitavastatin

Outcome Measures

Primary Outcomes (1)

  • Patient's characteristic.

    Characteristic of patients treated with pitavastatin among the Polish population.

    5 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients of the Department of Cardiology and Adult Congenital Heart Diseases, Department of Endocrinology, and outpatient cardiology and endocrinology clinics who is taking pitavastatin.

You may qualify if:

  • patient takling pitavastatin based on the 2021 Polish Lipid Guidelines

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Polish Mother's Memorial Hospital Research Institute

Lodz, 93-338, Poland

RECRUITING

MeSH Terms

Conditions

Hypercholesterolemia

Condition Hierarchy (Ancestors)

HyperlipidemiasDyslipidemiasLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Central Study Contacts

Maciej Banach, MD,PhD, FNLA, FAHA,FESC, FASA

CONTACT

+48 42 2711599maciej.banach@icloud.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2025

First Posted

March 5, 2025

Study Start

June 1, 2024

Primary Completion (Estimated)

February 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

March 5, 2025

Record last verified: 2025-02

Locations

PL(1)